{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:02:19Z","timestamp":1780128139961,"version":"3.54.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.canep.2025.102952","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T18:56:56Z","timestamp":1762023416000},"page":"102952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Association between sociodemographic and clinical factors and utilization of hematopoietic cell transplant in acute myeloid leukemia from 2004 to 2020"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-5846","authenticated-orcid":false,"given":"Utsav","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9545-8769","authenticated-orcid":false,"given":"Aditya","family":"Ravindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam","family":"Bhetuwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0114-9773","authenticated-orcid":false,"given":"Shishir","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avantika","family":"Pyakuryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-1510","authenticated-orcid":false,"given":"Prajwal","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2025.102952_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11864-020-00765-5","article-title":"Treatment of relapsed acute myeloid leukemia","volume":"21","author":"Thol","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.canep.2025.102952_bib2","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2009.813","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: a systematic review and meta-analysis of prospective clinical trials","volume":"301","author":"Koreth","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2025.102952_bib3","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood-2006-06-025627","article-title":"Results of a HOVON\/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?","volume":"109","author":"Cornelissen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canep.2025.102952_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.canep.2025.102952_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","article-title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","volume":"107","author":"Niederwieser","year":"2021","journal-title":"haematol"},{"key":"10.1016\/j.canep.2025.102952_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.canep.2025.102952_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41409-018-0105-9","article-title":"Use of hematopoietic cell transplantation in younger patients with acute myeloid leukemia: a national cancer database study","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.canep.2025.102952_bib8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","article-title":"Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.canep.2025.102952_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.34604","article-title":"Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-hispanic black patients with TP53 -mutated acute myeloid leukemia","volume":"129","author":"Badar","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2025.102952_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220864","article-title":"Racial\/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period","volume":"14","author":"Utuama","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canep.2025.102952_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/9e6ee407-7782-4cf7-8e82-9f38c1d6739e","article-title":"The influence of social support on hematopoietic stem cell transplantation survival: a systematic review of literature","volume":"8","author":"Beattie","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canep.2025.102952_bib12","doi-asserted-by":"crossref","first-page":"632.e1","DOI":"10.1016\/j.jtct.2023.04.020","article-title":"The transplantation ecosystem: a new concept to improve access and outcomes for older allogeneic hematopoietic cell transplantation patients","volume":"29","author":"Wall","year":"2023","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.canep.2025.102952_bib13","unstructured":"2024, About the National Cancer Database. ACS. https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-cancer-database\/about\/. Accessed 25 Mar 2024."},{"key":"10.1016\/j.canep.2025.102952_bib14","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1016\/j.clml.2022.06.006","article-title":"Effect of age and socioeconomic factors in the utilization of chemotherapy in acute lymphoblastic leukemia (ALL): a seer database study of 16,196 patients","volume":"22","author":"Joshi","year":"2022","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.canep.2025.102952_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clml.2021.10.010","article-title":"Disparity in utilization of multiagent therapy for acute promyelocytic leukemia in the United States","volume":"22","author":"Dhakal","year":"2022","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.canep.2025.102952_bib16","first-page":"409.e1","article-title":"Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes","volume":"28","author":"Phelan","year":"2022","journal-title":"Transpl. Cell Ther."},{"key":"10.1016\/j.canep.2025.102952_bib17","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00277-019-03771-2","article-title":"Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the acute leukemia working party of the european society for blood and marrow transplantation (EBMT)","volume":"98","author":"Giebel","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.canep.2025.102952_bib18","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00277-020-04051-0","article-title":"Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century","volume":"99","author":"Yanada","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.canep.2025.102952_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2217\/fon-2017-0599","article-title":"Factors associated with receipt of hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"14","author":"Manikkam Umakanthan","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.canep.2025.102952_bib20","doi-asserted-by":"crossref","first-page":"279.e1","DOI":"10.1016\/j.jtct.2022.12.013","article-title":"An analysis of the worldwide utilization of hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"29","author":"Tokaz","year":"2023","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.canep.2025.102952_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/bloodadvances.2020003883","article-title":"COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience","volume":"5","author":"Maurer","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.canep.2025.102952_bib22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41409-022-01650-5","article-title":"Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis","volume":"57","author":"Maakaron","year":"2022","journal-title":"Bone Marrow Transpl."},{"issue":"25","key":"10.1016\/j.canep.2025.102952_bib23","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.2024027543","article-title":"Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"145","author":"Wuliji","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.canep.2025.102952_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canep.2025.102952_bib25","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.bbmt.2018.12.110","article-title":"Access to allogeneic hematopoietic cell transplantation (HCT) for patients with acute myeloid leukemia (AML) in the State of Virginia","volume":"25","author":"Arora","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.canep.2025.102952_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1158\/2159-8290.CD-20-1579","article-title":"Poor survival and differential impact of genetic features of black patients with acute myeloid leukemia","volume":"11","author":"Bhatnagar","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canep.2025.102952_bib27","doi-asserted-by":"crossref","first-page":"e947","DOI":"10.1016\/S2352-3026(21)00303-3","article-title":"Racial and ethnic survival disparities in patients with haematological malignancies in the USA: time to stop ignoring the numbers","volume":"8","author":"Bhatnagar","year":"2021","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.canep.2025.102952_bib28","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/cncr.25297","article-title":"Access to hematopoietic stem cell transplantation","volume":"116","author":"Joshua","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2025.102952_bib29","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood.2021012830","article-title":"Structural racism is a mediator of disparities in acute myeloid leukemia outcomes","volume":"139","author":"Abraham","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.canep.2025.102952_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2011.214","article-title":"Racial disparities in hematopoietic cell transplantation in the United States","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transpl."},{"issue":"5","key":"10.1016\/j.canep.2025.102952_bib31","article-title":"Improving unrelated donor equity: assessing mismatched donor opportunities with real-world data in a minority-predominant cohort","volume":"30","author":"Hammami","year":"2024","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.canep.2025.102952_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1200\/OP.23.00243","article-title":"Financial toxicity and quality of life in patients undergoing stem-cell transplant evaluation: a single-center analysis","volume":"20","author":"Hussaini","year":"2024","journal-title":"JCO Oncol. Pr."},{"issue":"8","key":"10.1016\/j.canep.2025.102952_bib33","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.3390\/curroncol29080412","article-title":"Access to hematopoietic stem cell transplant in Canada for patients with acute myeloid leukemia","volume":"29","author":"Morakinyo","year":"2022","journal-title":"Curr. Oncol."},{"issue":"32","key":"10.1016\/j.canep.2025.102952_bib34","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1200\/JCO.2017.73.6728","article-title":"Effects of education and income on treatment and outcome in patients with acute myeloid leukemia in a tax-supported health care system: a national population-based cohort study","volume":"35","author":"\u00d8stg\u00e5rd","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2025.102952_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1186\/s12885-019-6093-3","article-title":"Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients","volume":"19","author":"Berger","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canep.2025.102952_bib36","series-title":"Social determinants of health [Internet]","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.canep.2025.102952_bib37","series-title":"A conceptual framework for action on the social determinants of health","author":"Solar","year":"2010"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125002127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125002127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:35:30Z","timestamp":1780126530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782125002127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"alternative-id":["S1877782125002127"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102952","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between sociodemographic and clinical factors and utilization of hematopoietic cell transplant in acute myeloid leukemia from 2004 to 2020","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102952"}}